KfW

CryoTherapeutics GmbH, founded in 2009 and based in Cologne, Germany, specializes in developing a proprietary cryotherapy system aimed at treating coronary artery disease, which is a leading cause of heart attacks. The company focuses on demonstrating clinical benefits and advancing early-stage commercialization of its innovative catheter system that employs cryoenergy to address issues related to diseased coronary arteries. By proving the safety and efficacy of cryoenergy in the cardiovascular context, CryoTherapeutics aims to provide heart surgeons with an effective tool to prevent heart attacks and enhance patient outcomes.

Everphone GmbH, founded in 2016 and based in Berlin, Germany, specializes in the rental of smartphones and tablets for employees. The company provides a comprehensive solution that includes device procurement, logistics, and mobile device management, allowing organizations to efficiently manage their mobile device needs. Everphone's proprietary software platform facilitates direct interaction with employees through various digital channels, enabling them to select and borrow devices on a rental basis. Additionally, the company offers services for the repair, replacement, and exchange of old or damaged devices, thereby supporting businesses in maintaining a seamless mobile experience without heavily taxing their internal IT resources.

Vectoflow GmbH, founded in 2014 and based in Gilching, Germany, specializes in the manufacture of fluid-dynamic metrology devices designed to assess fluid flow and dynamics. The company offers a range of standardized and customizable flow measurement technologies that accurately measure static and total pressure, velocity, and angle of attack. These devices are tailored to meet specific customer requirements regarding geometry, size, and material, making them suitable for various applications in motorsports, aviation, turbine machine development, and research. Vectoflow's manufacturing process enhances the robustness of its probes, ensuring reliable performance even in challenging environmental conditions, thus enabling clients to obtain durable solutions for their fluid measurement needs.

Electrochaea GmbH is a company based in Planegg, Germany, specializing in the development and commercialization of grid-scale power-to-gas energy storage technology. Founded in 2010, Electrochaea's proprietary process converts low-cost and stranded electricity, along with carbon dioxide, into renewable natural gas, specifically methane, which is suitable for direct injection into the existing natural gas grid. This technology facilitates the storage of large quantities of renewable energy generated from wind and solar sources, providing solutions for utility-scale energy storage, grid balancing, and carbon recycling. Additionally, the company aims to contribute to the decarbonization of transportation and natural gas grids, thereby reducing greenhouse gas emissions. With operational facilities in Denmark and California, Electrochaea represents a significant advancement in the efficient storage and transmission of renewable energy.

Uniper is an international energy company headquartered in Düsseldorf, Germany, with approximately 11,000 employees. Established on January 1, 2016, following the separation of E.ON's fossil fuel assets, Uniper focuses on energy generation and trading. The company operates through three main segments: European Generation, Global Commodities, and Russian Power Generation. The European Generation segment encompasses a diverse portfolio, including coal, gas, oil, and combined heat and power plants, as well as hydroelectric, nuclear, biomass, and renewable energy facilities. The Global Commodities segment centralizes the company's energy trading activities, while the Russian Power Generation segment oversees its power generation operations within Russia. Through its integrated approach, Uniper combines advanced technology and expertise to meet the evolving needs of the energy market.

Electrochaea GmbH is a company based in Planegg, Germany, specializing in the development and commercialization of grid-scale power-to-gas energy storage technology. Founded in 2010, Electrochaea's proprietary process converts low-cost and stranded electricity, along with carbon dioxide, into renewable natural gas, specifically methane, which is suitable for direct injection into the existing natural gas grid. This technology facilitates the storage of large quantities of renewable energy generated from wind and solar sources, providing solutions for utility-scale energy storage, grid balancing, and carbon recycling. Additionally, the company aims to contribute to the decarbonization of transportation and natural gas grids, thereby reducing greenhouse gas emissions. With operational facilities in Denmark and California, Electrochaea represents a significant advancement in the efficient storage and transmission of renewable energy.

Productsup GmbH, founded in 2010 and based in Simmelsdorf, Germany, operates a cloud-based software platform specializing in product data management. As a leader in the product-to-consumer (P2C) segment, the company provides a comprehensive range of solutions that streamline commerce across various channels. Its platform facilitates feed management, product content syndication, marketplace experiences, and the onboarding of sellers and vendors. Productsup enables clients to structure, analyze, and edit product data effectively, allowing for the creation of optimized product feeds tailored to specific channels. The company processes over two trillion products monthly, serving more than 900 brands, including prominent names like IKEA and Sephora, and handles more data requests each month than Google’s consumer search service. Through its innovative approach, Productsup significantly enhances online visibility and overall performance for its clients in the competitive digital marketplace.

Cleverciti, founded in 2012 by Thomas Hohenacker, specializes in smart parking technologies aimed at optimizing outdoor parking operations. The company offers an intelligent, easy-to-deploy solution that enhances parking management by identifying available parking spaces and guiding drivers to them, thereby reducing traffic congestion and vehicle emissions. Cleverciti's platform uniquely integrates intelligent parking detection with driver communication, enabling organizations to leverage data for various operational needs, including marketing and customer service. With a presence in multiple sectors such as retail, smart cities, healthcare, and transportation, Cleverciti positions itself as a leader in the smart parking industry. The company operates globally, with headquarters in Munich and Chicago, and provides comprehensive sales, professional services, and customer support to meet the needs of its clients.

Kraftwerk Group is a German renewable energy company founded in 2016, specializing in the development of advanced fuel cells that convert various fuels—such as natural gas, liquified gas, gasoline, and kerosene—into electricity. These fuel cells are designed for a diverse array of applications, including transportation solutions like e-bikes, passenger vehicles, light commercial vehicles, motorhome RVs, and medium-duty trucks. Additionally, Kraftwerk's technology supports stationary and portable systems, making it suitable for small and mid-size applications, emergency power, waste-to-energy projects, and IoT charging solutions. The company is also known for manufacturing nanocoated full metallic tubes, which are integral to building compact and efficient fuel cells for mobile use.

CureVac is a clinical-stage biopharmaceutical company based in Germany, established in 2000, that specializes in developing vaccines and therapies utilizing messenger ribonucleic acid (mRNA). The company focuses on both prophylactic and therapeutic applications of mRNA, enabling the human body to produce proteins that combat various diseases. CureVac's innovative pipeline includes mRNA-based cancer immunotherapies, such as CV9104, which is in Phase IIb development for prostate cancer, as well as RNActive vaccines against infectious diseases and RNArt molecular therapies designed to stimulate the production of therapeutic proteins. Additionally, the company has collaborated with GSK to advance second-generation vaccines for seasonal influenza and COVID-19, alongside an avian influenza vaccine, while also exploring mRNA therapies for oncology and other conditions affecting the liver and eyes.

Adidas, established in 1949, is a global leader in the sporting goods industry, renowned for its innovative athletic and casual footwear, apparel, and accessories. Headquartered in Herzogenaurach, Germany, the company designs, manufactures, and markets products under its iconic three-stripe brand. Adidas caters to a broad range of consumers, from professional athletes to casual wear enthusiasts, with a focus on performance, style, and sustainability. The brand's diverse product portfolio, spanning categories like football, running, training, basketball, and originals, allows it to address multiple consumer needs and market opportunities. Adidas sells its products through a global network of owned retail stores, franchise stores, wholesale partners, and e-commerce platforms, reaching over 160 countries.

GNA Biosolutions is a molecular technology company located in Martinsried, Germany, specializing in innovative diagnostic devices for detecting and analyzing DNA. Their core technology, Pulse Controlled Amplification, enhances molecular testing by integrating ultrafast nucleic acid amplification with intrinsic sample preparation. This advancement allows for efficient and simplified diagnosis of human pathogens in laboratory settings, as well as on-site applications and Point of Care scenarios. GNA Biosolutions aims to make the benefits of molecular testing accessible to a broader audience, facilitating rapid and accurate results from sample collection to analysis.

OMEICOS Therapeutics GmbH is a Berlin-based company founded in 2013 that specializes in developing novel therapeutics for cardiovascular diseases and other health conditions. The company focuses on small molecule therapies derived from natural metabolites of omega-3 fatty acids, which exhibit a unique mode of action. These substances activate an endogenous cardio-protective signaling pathway, providing both anti-arrhythmic effects and curative benefits by stabilizing heart rhythm and preventing electrical and structural remodeling of the heart. In addition to cardiovascular applications, OMEICOS also explores treatments for inflammatory and ophthalmic diseases, aiming to deliver safe and effective therapeutic options for various medical indications.

VEACT GmbH, founded in 2010 and headquartered in Munich, Germany, specializes in providing software solutions for after-sales marketing in the automotive industry. The company develops a platform that digitizes marketing processes, leveraging self-learning technology and extensive automotive expertise. By integrating various data sources, including invoices, service histories, and customer surveys, VEACT creates comprehensive customer profiles that facilitate predictive customer intelligence. This approach allows automotive dealerships and manufacturers to enhance the efficiency of their marketing and sales operations, ultimately resulting in reduced costs, improved customer loyalty, and increased revenue.

Implandata Ophthalmic Products GmbH is a medical device company based in Hanover, Germany, founded in 2010. It specializes in developing innovative solutions for the treatment and management of glaucoma, a prevalent eye disease. The company's flagship product, Eyemate, is an implantable micro sensor designed for continuous intraocular pressure measurement. This biocompatible device allows for 24-hour monitoring without compromising the patient's vision or overall well-being. By integrating advanced medical technology with information technology, Implandata aims to enhance the efficiency of glaucoma therapy, benefiting patients, their families, and caregivers. The company's focus on addressing unmet needs in glaucoma care positions it as a significant player in the ophthalmic medical device sector.

Acousia Therapeutics GmbH is a biotech company based in Tübingen, Germany, founded in 2012. It focuses on developing small molecule drugs aimed at treating hearing loss through local application. The company's innovative approach targets the regeneration of sensory hair cells in the inner ear, which are essential for hearing. By stimulating cellular regeneration from supporting cells, Acousia's therapies aim to restore hearing in patients affected by various conditions, including noise trauma, ototoxic drug treatment, and sudden deafness. Additionally, its research and development efforts are directed towards addressing age-related hearing decline.

Hemovent, based in Aachen, Germany, is a privately held medical technology company focused on developing a portable ECMO (Extracorporeal Membrane Oxygenation) unit. Founded by Christof Lenz and Oliver Marseille, the company aims to create an innovative device that supports or replaces heart and lung functions in cases of cardiac or respiratory failure. Hemovent's portable unit provides critical respiratory support for patients whose lungs are severely compromised, acting as a temporary life support system that takes over heart function during acute heart failure. This technology allows hospitals to stabilize patients and address the underlying issues leading to the failure while enabling patient mobility, thereby enhancing treatment options and outcomes.

BigRep, established in 2014, is a global leader in large-format Fused Filament Fabrication (FFF) 3D printing. Headquartered in Berlin with offices in Boston and Singapore, the company specializes in developing easy-to-use additive manufacturing solutions. BigRep's German-engineered 3D printers enable businesses, from start-ups to Fortune 100 companies, to accelerate innovation and rethink manufacturing by efficiently transitioning from prototyping to production. Through strategic partnerships and collaborations, BigRep offers complete additive manufacturing solutions, including industrial 3D printers, software, and advanced materials. Notably, BigRep's printers can print objects at a 1:1 scale, transforming the manufacturing process and helping companies bring products to market faster.

OMEICOS Therapeutics GmbH is a Berlin-based company founded in 2013 that specializes in developing novel therapeutics for cardiovascular diseases and other health conditions. The company focuses on small molecule therapies derived from natural metabolites of omega-3 fatty acids, which exhibit a unique mode of action. These substances activate an endogenous cardio-protective signaling pathway, providing both anti-arrhythmic effects and curative benefits by stabilizing heart rhythm and preventing electrical and structural remodeling of the heart. In addition to cardiovascular applications, OMEICOS also explores treatments for inflammatory and ophthalmic diseases, aiming to deliver safe and effective therapeutic options for various medical indications.

Acousia Therapeutics GmbH is a biotech company based in Tübingen, Germany, founded in 2012. It focuses on developing small molecule drugs aimed at treating hearing loss through local application. The company's innovative approach targets the regeneration of sensory hair cells in the inner ear, which are essential for hearing. By stimulating cellular regeneration from supporting cells, Acousia's therapies aim to restore hearing in patients affected by various conditions, including noise trauma, ototoxic drug treatment, and sudden deafness. Additionally, its research and development efforts are directed towards addressing age-related hearing decline.

amcure GmbH is a clinical-stage biopharmaceutical company based in Eggenstein-Leopoldshafen, Germany, focused on the research and development of peptide-based compounds designed to treat highly metastatic forms of squamous cancer. Founded in 2011 as a spin-off from the Karlsruhe Institute of Technology, amcure is dedicated to targeting the tumor-specific co-receptor CD44v6, which plays a critical role in activating various receptor tyrosine kinase pathways. Their lead candidate, AM001, effectively inhibits pathways associated with vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF), providing a novel therapeutic approach to combat metastatic tumors. The company has advanced its first-in-class CD44v6 inhibitor, AMC303, into clinical development for solid tumors as of late 2016, aiming to improve treatment options for cancers such as pancreatic, head and neck, gastric, colorectal, breast, and lung cancer.

Arzneimittelwerk Warngau develops and markets drug delivery systems. Its portfolio includes active ingredient/biodegradable implants and transdermal systems in the areas of oncology, pain therapy, and neurology. It focuses on transdermal passive and microchip controlled patches, as well as subcutaneous biodegradable implants. Wilfried Fischer founded Arzneimittelwerk Warngau in 2008. It has its headquarters in Warngau in Germany.

CryoTherapeutics GmbH, founded in 2009 and based in Cologne, Germany, specializes in developing a proprietary cryotherapy system aimed at treating coronary artery disease, which is a leading cause of heart attacks. The company focuses on demonstrating clinical benefits and advancing early-stage commercialization of its innovative catheter system that employs cryoenergy to address issues related to diseased coronary arteries. By proving the safety and efficacy of cryoenergy in the cardiovascular context, CryoTherapeutics aims to provide heart surgeons with an effective tool to prevent heart attacks and enhance patient outcomes.

fromAtoB GmbH operates a travel search engine that facilitates the comparison and integration of various modes of transportation across Europe, North America, and internationally. Founded in 2008 and based in Munich, Germany, the company provides users with access to a wide range of transportation options, including trains, flights, rideshares, long-distance buses, taxis, rental cars, and public transportation. Its platform serves as a multimodal journey planner, allowing users to search for and compare travel deals while also enabling secure bookings with different transport providers.

readfy GmbH, founded in 2013 and based in Düsseldorf, Germany, operates a digital reading platform that allows users to read e-books on their tablets or smartphones. The platform offers a wide range of genres including classical literature, crime, science fiction, romance, non-fiction, and children's books, among others, and features titles in multiple languages such as English and Spanish. readfy's innovative approach aims to create a social reading experience, providing users with unlimited access to digital content at no cost. This model seeks to disrupt traditional publishing practices while catering to the evolving needs of readers in a digital age.

Hemovent, based in Aachen, Germany, is a privately held medical technology company focused on developing a portable ECMO (Extracorporeal Membrane Oxygenation) unit. Founded by Christof Lenz and Oliver Marseille, the company aims to create an innovative device that supports or replaces heart and lung functions in cases of cardiac or respiratory failure. Hemovent's portable unit provides critical respiratory support for patients whose lungs are severely compromised, acting as a temporary life support system that takes over heart function during acute heart failure. This technology allows hospitals to stabilize patients and address the underlying issues leading to the failure while enabling patient mobility, thereby enhancing treatment options and outcomes.

Trinckle is a Berlin-based company specializing in software solutions for additive manufacturing. Its primary product, paramate, automates design processes and offers a platform for advanced product configuration. This technology allows for customer-specific adaptations across various applications, including tailored prostheses, optimized industrial components, low-volume jigs and fixtures, and personalized lifestyle products. By leveraging industrial machines and automated processes, Trinckle's platform streamlines complex design tasks, enabling businesses to efficiently transform digital designs into 3D printed products. This approach not only enhances customization but also makes 3D printing services more accessible and cost-effective for a diverse range of industries.

Cleverciti, founded in 2012 by Thomas Hohenacker, specializes in smart parking technologies aimed at optimizing outdoor parking operations. The company offers an intelligent, easy-to-deploy solution that enhances parking management by identifying available parking spaces and guiding drivers to them, thereby reducing traffic congestion and vehicle emissions. Cleverciti's platform uniquely integrates intelligent parking detection with driver communication, enabling organizations to leverage data for various operational needs, including marketing and customer service. With a presence in multiple sectors such as retail, smart cities, healthcare, and transportation, Cleverciti positions itself as a leader in the smart parking industry. The company operates globally, with headquarters in Munich and Chicago, and provides comprehensive sales, professional services, and customer support to meet the needs of its clients.

BigRep, established in 2014, is a global leader in large-format Fused Filament Fabrication (FFF) 3D printing. Headquartered in Berlin with offices in Boston and Singapore, the company specializes in developing easy-to-use additive manufacturing solutions. BigRep's German-engineered 3D printers enable businesses, from start-ups to Fortune 100 companies, to accelerate innovation and rethink manufacturing by efficiently transitioning from prototyping to production. Through strategic partnerships and collaborations, BigRep offers complete additive manufacturing solutions, including industrial 3D printers, software, and advanced materials. Notably, BigRep's printers can print objects at a 1:1 scale, transforming the manufacturing process and helping companies bring products to market faster.

Aquila biolabs GmbH is a German technology company established in 2014 and located in Baesweiler, Germany. It specializes in the development of innovative laboratory devices aimed at optimizing bioprocesses in bioreactors and incubation shakers. The company's product lineup includes the Cell Growth Quantifier (CGQ), Cell Growth Quantifier BIOR (CGQ BIOR), and the Liquid Injection System (LIS). These solutions feature smart sensors and data analytics software that facilitate real-time, non-invasive monitoring of cell growth in shake flasks. By providing automated and process-optimizing analysis, Aquila biolabs enables research scientists to obtain actionable insights during the cultivation of therapeutic products in various experimental settings.

Sicoya GmbH, founded in January 2015 as a spin-off from TU Berlin, specializes in designing, packaging, and selling silicon photonics-based application specific photonic integrated circuits (ASPICs). The company offers its ASPICs as bare dies or packaged chips and has developed miniature silicon photonics modulators that combine traditional CMOS processing with optical components. Since entering the market for data center interconnects in 2017, Sicoya has introduced a 100G transceiver chip that integrates both electronics and optics on a single chip. The company has received initial purchase orders for qualification units and is preparing customer samples for major data center players. Sicoya aims to enhance internet connectivity in next-generation data centers, facilitating the development of new internet services through its power-efficient and scalable optical transceiver solutions.

VEACT GmbH, founded in 2010 and headquartered in Munich, Germany, specializes in providing software solutions for after-sales marketing in the automotive industry. The company develops a platform that digitizes marketing processes, leveraging self-learning technology and extensive automotive expertise. By integrating various data sources, including invoices, service histories, and customer surveys, VEACT creates comprehensive customer profiles that facilitate predictive customer intelligence. This approach allows automotive dealerships and manufacturers to enhance the efficiency of their marketing and sales operations, ultimately resulting in reduced costs, improved customer loyalty, and increased revenue.

Datapine GmbH, founded in 2012 and based in Berlin, Germany, specializes in developing data visualization and business intelligence (BI) software as a service (SaaS). Its platform offers a range of tools for business analysis, data visualization, and reporting, making it accessible to both technical and non-technical users. This enterprise-grade solution facilitates the merging of diverse data sets without the need for extensive database restructuring, enabling users to explore and visualize data seamlessly. Datapine serves a variety of sectors, including energy, healthcare, financial services, logistics, and retail, providing not only BI tools but also consulting and coaching services. The company aims to lead the innovation in the BI market for small and medium-sized enterprises, helping organizations make informed decisions by uncovering insights and trends within their data.

Minodes GmbH, founded in 2013 and based in Berlin, Germany, provides a platform that enhances the performance of offline retail stores. The company's services focus on consumer analytics, allowing retailers to gain insights into factors affecting customer behavior and in-store revenue. By utilizing this platform, retailers can optimize their operations, store layouts, and marketing strategies to cater to various customer segments, from first-time visitors to loyal customers. Minodes also offers tools for launching location-based mobile marketing campaigns, enabling retailers to drive store traffic and engage consumers effectively. As of May 2017, Minodes operates as a subsidiary of Telefónica Germany NEXT GmbH.

OMEICOS Therapeutics GmbH is a Berlin-based company founded in 2013 that specializes in developing novel therapeutics for cardiovascular diseases and other health conditions. The company focuses on small molecule therapies derived from natural metabolites of omega-3 fatty acids, which exhibit a unique mode of action. These substances activate an endogenous cardio-protective signaling pathway, providing both anti-arrhythmic effects and curative benefits by stabilizing heart rhythm and preventing electrical and structural remodeling of the heart. In addition to cardiovascular applications, OMEICOS also explores treatments for inflammatory and ophthalmic diseases, aiming to deliver safe and effective therapeutic options for various medical indications.

GNA Biosolutions is a molecular technology company located in Martinsried, Germany, specializing in innovative diagnostic devices for detecting and analyzing DNA. Their core technology, Pulse Controlled Amplification, enhances molecular testing by integrating ultrafast nucleic acid amplification with intrinsic sample preparation. This advancement allows for efficient and simplified diagnosis of human pathogens in laboratory settings, as well as on-site applications and Point of Care scenarios. GNA Biosolutions aims to make the benefits of molecular testing accessible to a broader audience, facilitating rapid and accurate results from sample collection to analysis.

WeSustain is a company based in Buxtehude, Germany, that specializes in web-based software designed for enterprise sustainability management. Founded in 2010, WeSustain's software provides management support that assists organizations in adopting environmentally friendly practices across their products, processes, and technologies. The platform enables clients to implement a comprehensive sustainability management solution, allowing them to measure, improve, and report on their sustainability performance globally while addressing associated risks. Additionally, the software encompasses features such as organizational models, reporting standards, compliance management, and stakeholder surveys, which help enterprises enhance efficiency and effectively communicate their sustainability efforts.

Electrochaea GmbH is a company based in Planegg, Germany, specializing in the development and commercialization of grid-scale power-to-gas energy storage technology. Founded in 2010, Electrochaea's proprietary process converts low-cost and stranded electricity, along with carbon dioxide, into renewable natural gas, specifically methane, which is suitable for direct injection into the existing natural gas grid. This technology facilitates the storage of large quantities of renewable energy generated from wind and solar sources, providing solutions for utility-scale energy storage, grid balancing, and carbon recycling. Additionally, the company aims to contribute to the decarbonization of transportation and natural gas grids, thereby reducing greenhouse gas emissions. With operational facilities in Denmark and California, Electrochaea represents a significant advancement in the efficient storage and transmission of renewable energy.

Implandata Ophthalmic Products GmbH is a medical device company based in Hanover, Germany, founded in 2010. It specializes in developing innovative solutions for the treatment and management of glaucoma, a prevalent eye disease. The company's flagship product, Eyemate, is an implantable micro sensor designed for continuous intraocular pressure measurement. This biocompatible device allows for 24-hour monitoring without compromising the patient's vision or overall well-being. By integrating advanced medical technology with information technology, Implandata aims to enhance the efficiency of glaucoma therapy, benefiting patients, their families, and caregivers. The company's focus on addressing unmet needs in glaucoma care positions it as a significant player in the ophthalmic medical device sector.

AYOXXA Biosystems GmbH is a life science tools company based in Cologne, Germany, with additional offices in Singapore and Boston, Massachusetts. Founded in 2010, AYOXXA specializes in developing a proprietary technology platform for multiplexed protein analysis. This platform, which utilizes In-situ Encoded Bead-based Arrays, enables users to simultaneously measure multiple protein markers associated with various health conditions, including cancer, allergies, cardiovascular diseases, and infectious diseases. AYOXXA's innovative biochips merge biological analysis with information technology, expanding the potential applications in biomedical research. The company also offers biomarker kits to facilitate the identification and quantification of proteins and other biomolecular analytes.

Streetspotr GmbH is a retail intelligence company based in Nürnberg, Germany, that operates a smartphone application connecting businesses with a mobile workforce across Europe. The app allows businesses to post tasks, which are then notified to Streetspotr workers already present in the task location. This service generates real-time data and insights that assist brands and retailers in understanding products and promotions in-store, ultimately enhancing the shopper experience and driving in-store sales. Streetspotr's solutions cater to various sectors, including market research, consumer goods, and retail. In November 2018, the company was acquired by POSpulse GmbH, further expanding its capabilities in the retail intelligence space.

flinc AG, founded in 2010 and based in Ludwigshafen, Germany, operates a pioneering social mobility network application designed to facilitate real-time ridesharing by matching drivers and passengers. This innovative platform allows users to connect via desktop, smartphone, or navigation devices, ensuring a seamless experience for sharing everyday rides. By integrating navigation software, flinc enables drivers to reach passengers directly without the need for phone calls or text messages. The app's advanced route-matching algorithm can identify riders along the driver's route, calculate detours, and determine pricing. Users can select their match preferences, ranging from direct contacts to broader peer groups. Flinc also offers specialized solutions for companies and public transit organizations, promoting environmentally friendly commuting options. Its focus is primarily on short- to medium-length journeys, with integrated local transit schedules to enhance user convenience. As a subsidiary of moovel GmbH since 2017, flinc continues to develop its unique blend of technology, user experience design, and business development to advance urban mobility solutions.

Simplesurance GmbH, established in 2012 and based in Berlin, Germany, specializes in developing cross-selling software solutions for e-commerce platforms. Their primary product, Simplesurance, integrates into online shops' checkout processes, enabling customers to purchase insurance for their products at the point of sale. This allows e-commerce and electronics manufacturers to generate additional revenue by offering insurance alongside their products. Simplesurance also provides a digital broker solution, enabling customers to manage their insurance policies conveniently on their smartphones. The company has a presence in both Germany and Japan.

Capical GmbH specializes in the development and marketing of advanced electrocardiography (ECG) devices that utilize capacitive electrodes for contact-free patient monitoring. Founded in 2010 and based in Braunschweig, Germany, the company has established itself as a leader in capacitive sensor technology, which has applications beyond healthcare, including monitoring driver states in vehicles and physiological parameters in furniture such as chairs and beds. Capical's innovative approach allows for the continuous monitoring of heart and respiratory rates, cardiac arrhythmias, and other vital signs without direct skin contact, enhancing patient comfort and safety. The company also engages in extensive research and development to integrate its monitoring solutions into various products, supporting clients from initial prototyping to serial production. Capical has received several awards for its technological advancements and is recognized for its pioneering work in medically approved capacitive ECG devices, aiming to improve quality of life for elderly and ill individuals while also enhancing safety in automated driving scenarios.

miacosa.de is operated by the Endorsed Goods GmbH. miacosa.de is a social shopping concept from Germany based in Cologne. Social Shopping the miacosa way means that members select their personal shopping team of experts and celebrities that present products they love on miacosa.de Miacosa is for members only. The free service starts with products from the fields of Health Style, Home & Living, Kitchen and fashion accessories.

Sirion Biotech specializes in viral vector technology, which is essential for delivering genetic material into cells and developing innovative therapeutics, such as gene therapy for cancer. Founded in 2007, the company has become a global leader in gene modification of mammalian cells, offering a range of viral vector types, including adenovirus, adeno-associated virus (AAV), and lentivirus, all available within weeks. Sirion Biotech supports both academic and industry sectors through various commercial arrangements, including fee-for-service and licensing agreements. The company has experienced significant growth, with an annual increase of 70% since its inception, and has successfully completed over 500 projects. With offices in Munich, Tokyo, New Hampshire, and Tel Aviv, Sirion Biotech is well-positioned to meet the needs of researchers and developers in the field of gene therapy. The company is privately held and actively seeks new investors to support its ongoing growth and technological advancements in the rapidly evolving biotechnology industry.

Orpheus GmbH, founded in 2005 by Dr. Joerg Dittrich and Michael Lauer, specializes in software solutions for spend and procurement performance management. Based in Nuremberg, Germany, with additional offices in Mainz and Cologne, the company offers a range of products, including SpendControl for procurement controlling and spending management, and InitiativeTracker for managing sourcing initiatives. Orpheus also provides data management solutions such as a data consolidation tool and DeltaClass for automated classification of invoices and orders. To enhance data security, the company offers the DataMaskingSuite. Additionally, Orpheus develops custom business intelligence solutions and provides consulting services in spend management and data management, assisting clients with system design, report implementation, and data validation. Its clientele includes small, medium, and large enterprises in Germany and internationally, with notable partnerships among innovative DAX and MDAX companies. As of February 2020, Orpheus operates as a subsidiary of McKinsey & Company, Inc.

ZooRoyal is an online platform that offers accessories and supplies for pet dogs, cats, reptiles, horses, fish, and more. Its operations are based in Würselen, Germany.

Clickworker GmbH is a leading provider of crowdsourcing solutions based in Essen, Germany, specializing in internet-based services both domestically and internationally. Founded in 2005, the company has built a large network of over 6 million freelancers, known as Clickworkers, across Europe, America, and Asia. Clickworker offers a wide range of services, including web research, text creation, categorization, surveys, and mobile crowdsourcing, all delivered in 18 languages and over 30 target markets. The company efficiently breaks down projects into micro tasks that are completed by qualified Clickworkers, ensuring high-quality results through a quality assurance process. Additionally, Clickworker provides a self-service marketplace for smaller tasks, enabling clients to access standardized solutions for text creation, surveys, and sentiment analysis. Its cloud platform enhances data management for e-commerce, offering services such as search engine optimization and data authentication, which help clients accelerate project execution and achieve cost savings. The company was previously known as humanGrid GmbH until its name change in 2013.

Regiohelden GmbH, founded in 2010 and based in Stuttgart, Germany, specializes in providing online marketing services tailored for small businesses, entrepreneurs, and regional companies. The company focuses on search engine optimization and marketing, helping local advertisers reach their online audience, convert prospects into clients, and measure campaign results effectively. Regiohelden enables its clients to leverage the internet for business growth, supporting them with targeted digital marketing strategies.

avandeo, a Munich, Germany- and Shanghai, China-based startup that operates an online destination for designer furniture and home accessories.

Zalando is a leading European online fashion platform based in Berlin, founded in 2008. It offers a wide assortment of clothing, footwear, accessories, and beauty products, featuring over 7,000 brands and catering to nearly 50 million active customers across 25 markets. The company has established a significant presence in the DACH region, which includes Germany, Austria, and Switzerland, accounting for a substantial portion of its revenue. Zalando aims to provide an exceptional online shopping experience by continuously enhancing its technology, logistics, and marketing strategies. Its logistics network includes 13 fulfillment centers strategically located to efficiently serve local customer needs. As Europe's largest pure-play online fashion retailer, Zalando strives to be the go-to destination for fashion inspiration, innovation, and interaction.

Orpheus GmbH, founded in 2005 by Dr. Joerg Dittrich and Michael Lauer, specializes in software solutions for spend and procurement performance management. Based in Nuremberg, Germany, with additional offices in Mainz and Cologne, the company offers a range of products, including SpendControl for procurement controlling and spending management, and InitiativeTracker for managing sourcing initiatives. Orpheus also provides data management solutions such as a data consolidation tool and DeltaClass for automated classification of invoices and orders. To enhance data security, the company offers the DataMaskingSuite. Additionally, Orpheus develops custom business intelligence solutions and provides consulting services in spend management and data management, assisting clients with system design, report implementation, and data validation. Its clientele includes small, medium, and large enterprises in Germany and internationally, with notable partnerships among innovative DAX and MDAX companies. As of February 2020, Orpheus operates as a subsidiary of McKinsey & Company, Inc.

Evidanza is a software provider specializing in business intelligence solutions, headquartered in Salching, Germany. Founded in 2001, the company focuses on developing software that transforms complex data into relevant insights, facilitating informed decision-making for businesses. Its offerings include tools for reporting, planning, OLAP analysis, risk management, cost calculations, and compliance with IFRS and US GAAP standards. Evidanza's software aims to digitize and optimize various commercial processes, including accounting, cost accounting, customer relationship management, and corporate planning. By enhancing data management and organizational efficiency, the company helps clients improve cash flow, refine their cost structures, and develop robust business models.

Subitec GmbH, founded in 2000 as a spin-off from the Fraunhofer Institute for Interfacial and Biotechnology, specializes in manufacturing microalgae biotechnology cultivation equipment and turn-key production systems. The company offers a range of Flat Panel Airlift Photobioreactors in various sizes, including 6 liter, 28 liter, 100 liter, and 180 liter volumes, along with essential components such as lighting systems, media feeds, temperature control, and harvesting tools. Subitec's systems are designed for diverse applications, including nutraceuticals, food and feed, aquaculture, cosmetics, research, and energy markets. The company provides solutions for indoor, outdoor, compact, and hybrid systems, as well as pilot plants, enabling clients to produce sustainable bio-products from microalgae. Based in Stuttgart, Germany, Subitec operates as a subsidiary of Roeser Medical GmbH & Co. KG.

Algiax Pharmaceuticals GmbH is a biotechnology company based in Erkrath, Germany, founded in April 2011. The company specializes in the discovery and development of innovative products aimed at treating nervous system diseases and dysfunctions, with a particular emphasis on neuropathic pain and spinal cord injuries. Algiax Pharmaceuticals develops molecules that inhibit the enzyme dehydroorotate dehydrogenase, addressing central nervous system disorders associated with chronic pain. The company has demonstrated financial stability, having raised 4.3 million Euros in Series A financing from a consortium of private and state-backed investors. Algiax Pharmaceuticals is committed to addressing significant unmet medical needs in the field of neurology.

Micropelt is a startup that emerged from a collaborative project between Infineon Technologies AG and the Fraunhofer Institute for Physical Measurement Techniques in Germany. The company specializes in developing thin film thermoelectric components through semiconductor manufacturing processes. Micropelt focuses on creating energy-harvesting systems that integrate micro-actuators and sensors. Its product offerings include thermoelectric cooling chips and thermoelectric generators designed for various applications, such as chip spot cooling, biomedical devices, heating, ventilation, and air conditioning systems, as well as fiber optics. These innovations aim to facilitate effective temperature management in individual rooms while contributing to CO2 reduction and enhancing user comfort. The company has secured funding from several financial institutions, enabling its growth and development within the thin-film technology sector.

Simplesurance GmbH, established in 2012 and based in Berlin, Germany, specializes in developing cross-selling software solutions for e-commerce platforms. Their primary product, Simplesurance, integrates into online shops' checkout processes, enabling customers to purchase insurance for their products at the point of sale. This allows e-commerce and electronics manufacturers to generate additional revenue by offering insurance alongside their products. Simplesurance also provides a digital broker solution, enabling customers to manage their insurance policies conveniently on their smartphones. The company has a presence in both Germany and Japan.

numares AG is a German company specializing in the development and marketing of software-based test systems for clinical diagnostics and life science research. Founded in 2004 and based in Regensburg, the company utilizes nuclear magnetic resonance (NMR) spectroscopy and machine learning to analyze metabolomic networks. Its AXINON in vitro diagnostic system produces numeric spectra that provide critical information regarding patients' disease statuses, particularly in the fields of cardiovascular diseases, nephrology, oncology, and neurology. By employing magnetic group signaling (MGS) technology, numares AG offers a reliable, efficient, and cost-effective solution for NMR-based diagnostics, positioning itself as a leader in commercial NMR analytics in Europe while providing expert support to its customers.

Intelligent Apps, founded by Niclaus Mewes and Sven Kuelper in 2009, is recognized for developing mytaxi, the first taxi app that creates a direct connection between passengers and drivers. This innovative platform has rapidly expanded, boasting over 7 million downloads and connecting 35,000 taxis across more than 40 cities worldwide, including major locations like Washington, Madrid, and Zurich. mytaxi enhances the taxi service experience by allowing drivers to operate as independent contractors, fostering a competitive environment that encourages high-quality service and customer ratings. The app provides transparency in the ordering process, enabling passengers to track their taxi's arrival and view driver details. Drivers benefit from a favorable cost model, paying only for completed trips. Intelligent Apps aims to advance urban mobility and solidify its leadership position in the industry by continuously improving its services and expanding its reach. The company also provides app development services for Daimler Mobility Services, further enhancing its capabilities in the mobility sector.

Humedics GmbH, founded in 2009 and based in Berlin, Germany, specializes in the development of a breath analysis device designed to assess liver function in patients suffering from liver failure. The company's key product, the LiMAx test, is a diagnostic system that includes a medical device, breath masks, and a diagnostic drug, enabling clinicians to quantitatively evaluate individual liver function. This technology supports various applications, such as assessing liver function before and after transplantation, planning liver surgeries, and evaluating conditions like liver cirrhosis. By providing rapid and precise measurements at the bedside, LiMAx facilitates informed decision-making for tailored medical treatments, thereby enhancing patient outcomes. The company has successfully used its technology with thousands of patients and is focused on expanding its global operations.

numares AG is a German company specializing in the development and marketing of software-based test systems for clinical diagnostics and life science research. Founded in 2004 and based in Regensburg, the company utilizes nuclear magnetic resonance (NMR) spectroscopy and machine learning to analyze metabolomic networks. Its AXINON in vitro diagnostic system produces numeric spectra that provide critical information regarding patients' disease statuses, particularly in the fields of cardiovascular diseases, nephrology, oncology, and neurology. By employing magnetic group signaling (MGS) technology, numares AG offers a reliable, efficient, and cost-effective solution for NMR-based diagnostics, positioning itself as a leader in commercial NMR analytics in Europe while providing expert support to its customers.

Sividon Diagnostics GmbH, founded in 2011 and based in Cologne, Germany, specializes in developing treatment-related diagnostic tests, particularly in the field of molecular tumor diagnostics. The company offers a portfolio that includes the ImmunoPredict biomarker test and the EndoPredict kit, an RNA expression test that evaluates the aggressiveness of breast cancer by analyzing 12 genes at a molecular level. As a management buyout from Siemens Healthcare Diagnostics, Sividon aims to enhance the quality of companion diagnostics in oncology, thereby enabling more individualized and evidence-based treatment decisions for cancer patients. The company benefits from the expertise of its team of experienced scientists and managers, as well as from a network of international experts in molecular diagnostics. Sividon operates as a subsidiary of Myriad Services GmbH.

Pay by Shopping is an innovative tool that can be used to reach new customers, increase website traffic, and to raise conversion rates. Available on browser games, via Mobile, and as a Facebook-App, Pay by Shopping enables users to earn virtual currency and items, such as rebates, from a Publisher by shopping at an Advertiser. It drives incremental revenue for Publishers while at the same time serving as a performance marketing tool for online Advertisers. Advertisers gain new customers and see increased sales. Current partnerships include Facebook, OTTO, Zalando, Ubisoft, and Bigpoint. Pay by Shopping is a product of deal united GmbH. The firm is based in Munich with offices in Paris and San Francisco.

Sirion Biotech specializes in viral vector technology, which is essential for delivering genetic material into cells and developing innovative therapeutics, such as gene therapy for cancer. Founded in 2007, the company has become a global leader in gene modification of mammalian cells, offering a range of viral vector types, including adenovirus, adeno-associated virus (AAV), and lentivirus, all available within weeks. Sirion Biotech supports both academic and industry sectors through various commercial arrangements, including fee-for-service and licensing agreements. The company has experienced significant growth, with an annual increase of 70% since its inception, and has successfully completed over 500 projects. With offices in Munich, Tokyo, New Hampshire, and Tel Aviv, Sirion Biotech is well-positioned to meet the needs of researchers and developers in the field of gene therapy. The company is privately held and actively seeks new investors to support its ongoing growth and technological advancements in the rapidly evolving biotechnology industry.

Vimecon GmbH, founded in 2005 and headquartered in Herzogenrath, Germany, specializes in the development and production of laser catheters specifically designed for the treatment of heart diseases, with a primary focus on atrial fibrillation. The company also manufactures a range of products for the medical technology and biotechnology sectors, including microscopically small catheters and micro materials handling techniques that facilitate precise measurement and dosage. Additionally, Vimecon provides advisory services to various clients in both academic and industrial research and development. Its innovations aim to enhance healthcare outcomes and support advancements in the treatment of cardiovascular diseases and cardiac arrhythmias.

CYNORA GmbH, founded in 2008 and headquartered in Bruchsal, Germany, specializes in the development and manufacture of organic electronics, particularly organic light-emitting diodes (OLEDs). The company focuses on creating highly efficient blue and green emitter systems utilizing Thermally Activated Delayed Fluorescence (TADF) technology. This innovative approach allows for the conversion of triplet excitons into light, thereby enhancing power efficiency and reducing electrical stress within OLED devices. As demand for thin, flexible screens with improved image quality and lower power consumption rises, CYNORA aims to provide added value to OLED producers with its iridium-free, purely organic emitter solutions. By addressing the challenges faced in developing stable and efficient blue emitters, CYNORA is positioned to support advancements in the AMOLED market and contribute to the evolution of display technology.

OctreoPharm Sciences GmbH is a biopharmaceutical company based in Berlin, Germany, specializing in the development of radiopharmaceuticals aimed at the diagnosis and treatment of neuroendocrine tumors. Founded in 2010, the company is engaged in creating theranostic antagonistic peptides that serve both diagnostic and therapeutic purposes. Its notable products include OPS201, designed for selective internal peptide receptor radionuclide therapy using radioisotopes like 90Y or 177Lu, and OPS202, which is a gallium-68 labeled somatostatin receptor antagonist intended for positron emission tomography. As of mid-2015, OctreoPharm Sciences operates as a subsidiary of Ipsen S.A.

Clickworker GmbH is a leading provider of crowdsourcing solutions based in Essen, Germany, specializing in internet-based services both domestically and internationally. Founded in 2005, the company has built a large network of over 6 million freelancers, known as Clickworkers, across Europe, America, and Asia. Clickworker offers a wide range of services, including web research, text creation, categorization, surveys, and mobile crowdsourcing, all delivered in 18 languages and over 30 target markets. The company efficiently breaks down projects into micro tasks that are completed by qualified Clickworkers, ensuring high-quality results through a quality assurance process. Additionally, Clickworker provides a self-service marketplace for smaller tasks, enabling clients to access standardized solutions for text creation, surveys, and sentiment analysis. Its cloud platform enhances data management for e-commerce, offering services such as search engine optimization and data authentication, which help clients accelerate project execution and achieve cost savings. The company was previously known as humanGrid GmbH until its name change in 2013.

SAW Instruments specializes in the development, manufacture, and distribution of analytical systems designed for the life sciences sector. The company's innovative equipment enables label-free analysis of biomolecular interactions, offering a combination of high sensitivity, stability, and user-friendliness. SAW Instruments' products are utilized by leading research institutions in Germany and Switzerland, reflecting their effectiveness and reliability in advanced scientific research.

Fairrank GmbH is a German-based company founded in 2004, operating as a subsidiary of Euro Serve Media GmbH since 2015. It specializes in providing search engine optimization (SEO) and marketing services to small and medium-sized businesses across Germany, Austria, and Switzerland. Fairrank's offerings include assessing clients' existing web presence for improvement, enhancing visitor numbers through tailored strategies, and delivering comprehensive digital marketing solutions such as social media marketing, content marketing, web development, and usability optimization. The company serves diverse industries via a network of sales representatives, aiming to boost clients' sales and productivity through effective online marketing strategies.

GILUPI GmbH is a medical device company based in Potsdam, Germany, specializing in the development and production of diagnostic products for the in vivo isolation of rare cells from circulating blood. The company's devices are specifically designed to isolate tumor cells by utilizing antibodies bound to a nano-detector, allowing for precise identification of circulating tumor cells. This technology enables healthcare professionals to perform in vivo isolation, supporting tailored therapeutic approaches for patients. GILUPI's products are CE certified, ensuring compliance with European health standards.

Based in Cologne, Germany, BLUE LION mobile GmbH is a tech startup that offers new types of communication and entertainment for the mobile phone. BLUE LION Mobile produces and distributes the mobile social-networking application and multiplayer gaming platform "qeep." Founded in 2006, the team is led by Cornelius Rost, Arefin Bashar Arif and Christian R. Schulte, who teamed up to head this venture after years of experience in the industries of telecommunications and hand-held devices.

Zimory GmbH specializes in carrier-grade cloud infrastructure management software tailored for cloud service providers, enterprises, and cloud brokers. Founded in 2007 and headquartered in Berlin, the company offers an intelligent Cloud Suite that simplifies, automates, and accelerates the creation, launch, and management of various cloud environments, including public, private, virtual private, and hybrid setups. Zimory's software enables the development of cloud marketplaces for enterprise services, applications, and infrastructure, allowing users to effectively leverage cloud computing's power and flexibility. Additionally, the company provides consulting, technical support services, and cloud management installations, serving global telecommunications carriers and government entities. Zimory has development centers in Erfurt, Germany, and Minsk, Belarus, as well as a subsidiary office in New York City. As of September 2016, Zimory GmbH is in liquidation.

VIOSO GmbH, founded in 2007 and based in Düsseldorf, Germany, specializes in automatic digital edge-blending and geometry alignment solutions for various visual applications worldwide. The company's offerings include VIOSO Player, a professional video playback software designed for mapping content on custom surfaces such as fulldome displays and 3D objects. Additional products include VIOSO Anyblend, an embedded solution for simulators and signage; VIOSO Anyblend VR & SIM for military and non-commercial applications; and Wings VIOSO, a media server tailored for large venues and events. VIOSO also provides high-resolution display technology through the VIOSO Blackbox 4K and auto-alignment solutions for video walls and digital signage. The company continues to innovate with customized projects and training services, all aimed at enhancing presentations and visual experiences. VIOSO's journey began with the "smartprojector" concept at Bauhaus University in Weimar, evolving into a comprehensive software suite that redefines how information is presented.

Phenex Pharmaceuticals AG is a drug discovery and development company founded in 2002 and headquartered in Ludwigshafen, Germany, with additional laboratories and offices in Heidelberg. The company specializes in small-molecule drug discovery, focusing on nuclear receptors to address various disease areas, including liver diseases, intestinal diseases, and cancer. Current research includes developing RORγt inverse agonists for autoimmune diseases and FXR agonists for non-alcoholic steatohepatitis. Phenex is dedicated to not only creating therapeutics for established targets but also identifying novel molecular mechanisms, which has led to the development of proprietary therapeutic small molecules. The company operates within the Biotech Cluster Rhine-Neckar, leveraging its expertise in biology and chemistry to advance innovative treatment options.

GreenPocket GmbH, founded in 2009 and based in Cologne, Germany, specializes in energy management software designed for utility companies. The company provides solutions for interpreting and visualizing smart metering data, including a household customer portal and energy management software tailored for commercial clients. Their offerings encompass various tools such as a web portal for real-time energy consumption visualization, a business customer portal for cost-saving comparisons, and smart home solutions that optimize the control of household appliances. By leveraging innovative technologies like artificial intelligence and data science, GreenPocket aims to create significant value from smart meter data, thereby supporting energy suppliers and corporate customers in the transition towards a more sustainable energy future. With experience in over 125 projects across 12 countries, GreenPocket is positioned as a trusted partner in the digitalization of the energy industry.

Locr GmbH is a company based in Braunschweig, Germany, that specializes in geo-based services and photo sharing. Established in 2006, Locr offers a platform known as locrExplorer, which allows users to browse and tag photos with location information through geotagging. This service visualizes locations on street maps and satellite images, providing insights about the photographed subjects and their surroundings. Additionally, Locr focuses on geo photography and geo-related print products, alongside providing software solutions for geotagging. The company also serves marketers by transforming data from geodata sources like OpenStreetMap into personalized maps and geo-information services, which help enhance mailing lists and improve engagement and response rates in marketing communications.

Galantos Pharma GmbH is a biotechnology company focused on developing drugs for the treatment of Alzheimer's disease and other neurodegenerative disorders. The company is advancing Memogain, an investigational pro-drug derived from galantamine, which aims to provide symptomatic relief and potential disease modification for patients with mild-to-moderate Alzheimer’s dementia. In addition to its drug development efforts, Galantos Pharma has established a technology platform for the screening and preclinical validation of drug candidates that target cholinergic and other neuro-receptors as well as various brain enzymes. Founded in 2005, the company is headquartered in Mainz, Germany.

Clickworker GmbH is a leading provider of crowdsourcing solutions based in Essen, Germany, specializing in internet-based services both domestically and internationally. Founded in 2005, the company has built a large network of over 6 million freelancers, known as Clickworkers, across Europe, America, and Asia. Clickworker offers a wide range of services, including web research, text creation, categorization, surveys, and mobile crowdsourcing, all delivered in 18 languages and over 30 target markets. The company efficiently breaks down projects into micro tasks that are completed by qualified Clickworkers, ensuring high-quality results through a quality assurance process. Additionally, Clickworker provides a self-service marketplace for smaller tasks, enabling clients to access standardized solutions for text creation, surveys, and sentiment analysis. Its cloud platform enhances data management for e-commerce, offering services such as search engine optimization and data authentication, which help clients accelerate project execution and achieve cost savings. The company was previously known as humanGrid GmbH until its name change in 2013.

Cuculus GmbH, founded in 2007 and based in Ilmenau, Germany, specializes in software solutions for the energy sector, focusing on smart metering and energy management. The company offers ZONOS, an IoT platform that facilitates the integration and management of various utility meters, including electric, gas, and water, into a cohesive digital framework. This platform supports energy suppliers, grid operators, telecommunications companies, and metering service providers in transitioning from traditional manual meters to intelligent, connected systems. With a team that combines expertise in information technology, telecommunications, and electrical engineering, Cuculus leverages advanced technology developed in collaboration with the Technical University Ilmenau and IDEO Laboratories. The company also has an office in Leipzig, enhancing its presence in one of Germany's key technology regions.

numares AG is a German company specializing in the development and marketing of software-based test systems for clinical diagnostics and life science research. Founded in 2004 and based in Regensburg, the company utilizes nuclear magnetic resonance (NMR) spectroscopy and machine learning to analyze metabolomic networks. Its AXINON in vitro diagnostic system produces numeric spectra that provide critical information regarding patients' disease statuses, particularly in the fields of cardiovascular diseases, nephrology, oncology, and neurology. By employing magnetic group signaling (MGS) technology, numares AG offers a reliable, efficient, and cost-effective solution for NMR-based diagnostics, positioning itself as a leader in commercial NMR analytics in Europe while providing expert support to its customers.

Curetis AG, founded in 2015 and based in Holzgerlingen, Germany, develops molecular diagnostics solutions aimed at detecting infectious diseases, pathogens, and antibiotic resistance markers. The company specializes in multiparameter testing, enabling the simultaneous analysis of various analytes in a single run. Its primary focus is on providing comprehensive panels for detecting severe bacterial infections, offering rapid diagnostic solutions that help physicians obtain early and actionable insights in managing infectious diseases and antimicrobial resistance. Curetis operates as a subsidiary of OpGen, Inc. and is positioned to expand its diagnostic capabilities into other clinical applications beyond infectious diseases in the future.

Elara Pharmaceuticals Gmbh provides research and pharmaceutical development services for new anti-cancer drugs. In addition Elara Pharmaceuticals Gmbh has discovered lead series of small, bioactive molecules that have anti-tumour activity, based on inhibitors of estrogen signaling and Aurora kinases. Elara Pharmaceuticals Gmbh was founded in 2006 and is based in Heidelberg, Germany.

Nevigo GmbH, based in Bochum, Germany, specializes in developing a multi-platform game engine tailored for video games. The company provides a range of tools and middleware that enhance the creation of story-driven content, allowing developers to craft engaging gaming experiences. Its offerings include advanced compositing methods, a grading system, and a camera system, all aimed at improving the storytelling aspects of games. Through its innovative platform, Nevigo supports game developers in producing high-quality, immersive gameplay.

Stream5 is a German video streaming company.

CorporateWorld GmbH operates a credit card based on-line travel management system for business travellers. It also offers travel management services. The company is based in Munich, Germany.

Metasonic AG is a Germany-based IT company founded in 2004 by Albert Fleischmann, specializing in enterprise software design and development. The company offers the Metasonic Suite, a platform for subject-oriented business process management that facilitates dynamic process applications and enhances communication among various business participants. In addition to its software solutions, Metasonic provides a variety of training courses focused on business process management and the Metasonic Suite tools, including standard trainings, certifications, and introductory sessions on the S-BPM methodology. The company collaborates with several international partners, such as Alius Consulting Services and Devoteam, to expand its reach and enhance its offerings.

Novaled AG is a technology provider specializing in organic light-emitting diode (OLED) technologies, targeting the organic electronics market. Based in Dresden, Germany, and established in 2003, the company focuses on high-efficiency, long-lifetime OLED structures, leveraging its expertise in synthetic and analytical chemistry. Novaled offers complete solutions that include its proprietary Doping technology and materials, catering to customers in various sectors, including televisions and mobile devices. The company has built strong partnerships with major players in the OLED industry and holds a robust intellectual property portfolio, with over 500 patents granted or pending. Additionally, Novaled maintains branch offices in Asia to support its global operations.

OXID eSales AG, headquartered in Freiburg, Germany, specializes in multi-channel e-commerce solutions, offering open source shopping cart software known as OXID eShop. Founded in 2003, the company serves both business-to-business (B2B) and business-to-consumer (B2C) markets, providing scalable and customizable e-commerce platforms. Major clients such as Lekkerland, Strenesse, Intersport, Gravis, and Deutsche Post utilize OXID's solutions for their online operations. The platform is designed for flexibility and rapid deployment, supported by a network of over 100 certified solution partners. OXID eShop integrates with the OXID eFire intelligence platform, which facilitates cloud-based e-commerce management, including online marketing, payment services, and intelligent search functionalities. This commercial open source software approach ensures high-quality development and long-term investment security for users, making it a valuable choice for medium-sized companies seeking to enhance their digital sales processes.

VIOSO GmbH, founded in 2007 and based in Düsseldorf, Germany, specializes in automatic digital edge-blending and geometry alignment solutions for various visual applications worldwide. The company's offerings include VIOSO Player, a professional video playback software designed for mapping content on custom surfaces such as fulldome displays and 3D objects. Additional products include VIOSO Anyblend, an embedded solution for simulators and signage; VIOSO Anyblend VR & SIM for military and non-commercial applications; and Wings VIOSO, a media server tailored for large venues and events. VIOSO also provides high-resolution display technology through the VIOSO Blackbox 4K and auto-alignment solutions for video walls and digital signage. The company continues to innovate with customized projects and training services, all aimed at enhancing presentations and visual experiences. VIOSO's journey began with the "smartprojector" concept at Bauhaus University in Weimar, evolving into a comprehensive software suite that redefines how information is presented.

Ubitexx GmbH develops and distributes management and security software for smartphones and mobile devices. It offers ubi-Suite, a centralized smartphone management suite of capabilities. The company also provides strategic mobile management consulting, training and installation, and technical support services. It serves banking, insurance, pharmaceuticals, energy, media, engineering, and automotive industries, as well as public sector. Ubitexx GmbH was founded in 2002 and is based in Munich, Germany with an additional office in Cambridge, Massachusetts.

Phenex Pharmaceuticals AG is a drug discovery and development company founded in 2002 and headquartered in Ludwigshafen, Germany, with additional laboratories and offices in Heidelberg. The company specializes in small-molecule drug discovery, focusing on nuclear receptors to address various disease areas, including liver diseases, intestinal diseases, and cancer. Current research includes developing RORγt inverse agonists for autoimmune diseases and FXR agonists for non-alcoholic steatohepatitis. Phenex is dedicated to not only creating therapeutics for established targets but also identifying novel molecular mechanisms, which has led to the development of proprietary therapeutic small molecules. The company operates within the Biotech Cluster Rhine-Neckar, leveraging its expertise in biology and chemistry to advance innovative treatment options.

QuinLogic is a German company specializing in quality assurance software for steel and aluminum mills, aimed at enhancing industrial mass production while maintaining high flexibility. By leveraging advanced computing power and storage capabilities, QuinLogic has created user-friendly software solutions that are currently operational in numerous high-end flat rolling mills worldwide. The software ensures consistent quality of slabs, plates, and coils, catering to demanding sectors such as automotive, aerospace, wind energy, and materials requiring high strength and wear resistance. Additionally, QuinLogic's software provides proactive support to address production issues promptly, thereby reducing deficiencies in customer products. Its seamless integration with existing manufacturing execution systems (MES), enterprise resource planning (ERP), and gauging systems enables comprehensive functionality across both current and new production lines.

Signature Diagnostics GmbH is a translational oncology and genomics company based in Potsdam, Germany, founded in 2004. The company specializes in the development of extensive biobanks comprising blood plasma and tumor tissue samples from cancer patients, particularly focusing on colorectal and lung cancers through multicenter prospective clinical studies. Signature Diagnostics also creates next-generation sequencing assays utilizing targeted gene panels and demonstrates expertise in ultra-deep sequencing tests that leverage circulating free DNA (cfDNA). These advancements aim to enhance non-invasive monitoring of treatment responses in cancer patients. Additionally, Signature has developed molecular oncology diagnostic products for early cancer detection and prognosis, which have been launched from its ISO 15189 certified service laboratory. The company collaborates with various clinical, pharmaceutical, and diagnostic partners to further its research and product development initiatives. As of February 2015, it operates as a subsidiary of Roche Holding AG.

Biontis GmbH specializes in developing automated processes for the biochemical analysis of complex liquid mixtures and manufactures a range of laboratory equipment. Founded in 2002 and based in Geesthacht, Germany, the company provides essential tools for laboratories involved in water analysis, food inspections, forensic medicine, and clinical diagnostics. Biontis offers a comprehensive array of products, including analytical procedures, test kits, SPE columns, reagents, and automation devices, all designed to facilitate efficient and innovative analytical processes. By streamlining treatment steps such as evaporation, heating, and dissolution, Biontis enables researchers to conduct more effective and cost-efficient analyses. The company's products are marketed primarily in Germany.

Locr GmbH is a company based in Braunschweig, Germany, that specializes in geo-based services and photo sharing. Established in 2006, Locr offers a platform known as locrExplorer, which allows users to browse and tag photos with location information through geotagging. This service visualizes locations on street maps and satellite images, providing insights about the photographed subjects and their surroundings. Additionally, Locr focuses on geo photography and geo-related print products, alongside providing software solutions for geotagging. The company also serves marketers by transforming data from geodata sources like OpenStreetMap into personalized maps and geo-information services, which help enhance mailing lists and improve engagement and response rates in marketing communications.

DIVOLUTION is a German company that offers testing and targeting technology.

Galantos Pharma GmbH is a biotechnology company focused on developing drugs for the treatment of Alzheimer's disease and other neurodegenerative disorders. The company is advancing Memogain, an investigational pro-drug derived from galantamine, which aims to provide symptomatic relief and potential disease modification for patients with mild-to-moderate Alzheimer’s dementia. In addition to its drug development efforts, Galantos Pharma has established a technology platform for the screening and preclinical validation of drug candidates that target cholinergic and other neuro-receptors as well as various brain enzymes. Founded in 2005, the company is headquartered in Mainz, Germany.

KINAXO Biotechnologies is a privately-held biotechnology company based in Munich/Martinsried, Germany. They are a service company specializing in chemical proteomics methods to support the successful development of small molecule drugs. As a spin-off of the Max Planck Institute of Biochemistry in Martinsried, they continuously expand and improve their technology platform in collaboration with the leading Max Planck laboratories of Axel Ullrich, Henrik Daub and Matthias Mann. KINAXO offers its clients extensive experience in cellular target profiling and other chemical proteomics applications.